By Counterforce Health Team in Fintepla (fenfluramine) —

Do You Qualify for Fintepla (Fenfluramine) Coverage by Cigna in Georgia? Decision Tree & Next Steps

Answer Box: Quick Eligibility Check

Most likely to get Fintepla (fenfluramine) approved by Cigna in Georgia: Diagnosed with Dravet syndrome or Lennox-Gastaut syndrome by a neurologist, failed 2+ antiseizure medications (like valproic acid, topiramate, clonazepam), enrolled in Fintepla REMS program with baseline echocardiogram completed. First step today: Have your neurologist submit prior authorization via Cigna provider portal with REMS enrollment forms and echo results. If denied, Georgia offers free external review within 60 days through the Department of Insurance.

Table of Contents

How to Use This Guide

This decision tree helps patients and families navigate Fintepla (fenfluramine) coverage with Cigna in Georgia. Start with the eligibility triage below to determine your approval likelihood, then follow the specific pathway for your situation.

Important: Fintepla requires enrollment in a special safety program (REMS) before any insurance will consider coverage. Your neurologist must complete this first—it's not optional.

Tip: Georgia residents have strong appeal rights through the state Department of Insurance. Even if Cigna initially denies coverage, many specialty drug appeals succeed with proper documentation.

Eligibility Triage: Do You Qualify?

Step 1: Confirmed Diagnosis

You need one of these diagnoses documented by a neurologist:

Dravet Syndrome:

  • Seizure onset before age 2 (typically under 1 year)
  • Normal development before seizures began
  • Prolonged seizures (often lasting >10 minutes)
  • Multiple seizure types including focal clonic or hemiclonic
  • Ideally confirmed by SCN1A genetic testing (found in ~85% of cases)

Lennox-Gastaut Syndrome (LGS):

  • Multiple seizure types (must include tonic seizures)
  • EEG showing slow spike-wave patterns (<2.5 Hz when awake)
  • Cognitive impairment or developmental delays
  • Onset typically between ages 1-8 years

Sources: Dravet Foundation diagnostic criteria, LGS diagnostic guidelines

Step 2: Prior Treatment History

Cigna requires evidence you've tried and failed at least 2 antiseizure medications, such as:

  • Valproic acid (Depakote)
  • Topiramate (Topamax)
  • Clonazepam (Klonopin)
  • Levetiracetam (Keppra)
  • Vigabatrin (Sabril)
  • Or combination therapy with clobazam, Epidiolex, or Diacomit

Source: Cigna Fintepla policy CNF-315

Step 3: REMS Enrollment Status

Required before any coverage consideration:

  • Prescriber enrolled in Fintepla REMS program
  • Baseline echocardiogram completed and submitted
  • Patient enrolled via REMS Patient Enrollment Form

Source: Fintepla REMS Program

If Likely Eligible: Document Checklist

✅ Medical Records Needed:

  • Neurologist consultation notes confirming Dravet syndrome or LGS diagnosis
  • EEG reports showing characteristic patterns (for LGS)
  • Genetic testing results (SCN1A mutation for Dravet, if available)
  • Seizure logs documenting frequency, duration, and types over past 6-12 months
  • Documentation of failed antiseizure medications with reasons (ineffective, intolerable side effects)

✅ REMS Documentation:

  • Completed Prescriber Enrollment Form
  • Patient Enrollment Form
  • Baseline echocardiogram results showing no contraindications
  • Patient Status Form authorizing treatment

✅ Insurance Submission:

  • Cigna prior authorization form (access via provider portal)
  • All medical documentation above
  • Letter of medical necessity from neurologist

Submission Path: Neurologist submits via Cigna provider portal or fax. Standard review takes 15-30 business days; expedited available for urgent cases.

When patients and clinicians need help turning insurance denials into successful appeals, Counterforce Health specializes in creating evidence-backed appeals that align with payer policies. The platform analyzes denial reasons and drafts targeted rebuttals using the right clinical evidence and procedural requirements for each insurance company.

If Possibly Eligible: Tests to Request

Missing Dravet Syndrome Confirmation:

  • Request SCN1A genetic testing panel
  • Video-EEG monitoring to capture seizure patterns
  • Detailed developmental history documentation
  • Temperature sensitivity testing (fever-induced seizures)

Missing LGS Confirmation:

  • Sleep-deprived EEG to capture slow spike-wave patterns
  • Cognitive assessment documentation
  • Video-EEG to confirm tonic seizures
  • Review of seizure types with neurologist

Incomplete Treatment History:

  • Trial of additional first-line antiseizure medications
  • Documentation of why specific medications failed
  • Combination therapy attempts if appropriate
  • Detailed medication history with dates and outcomes

Timeline to Re-apply: Most patients need 3-6 months to complete additional testing and treatment trials. Keep detailed seizure logs during this period.

If Not Yet Eligible: Alternative Options

Step Therapy Alternatives to Discuss:

  • Clobazam (Onfi) - often first-line for Dravet syndrome
  • Cannabidiol (Epidiolex) - FDA-approved for both conditions
  • Stiripentol (Diacomit) - specifically for Dravet syndrome
  • Rufinamide (Banzel) - for Lennox-Gastaut syndrome
  • Lamotrigine (Lamictal) - depending on seizure types

Preparing for Exception Requests:

  • Document why standard alternatives aren't suitable
  • Gather evidence of contraindications or prior failures
  • Request peer-to-peer review with Cigna medical director
  • Consider formulary exception request process

Source: Cigna formulary exception process

If Denied: Georgia Appeal Process

Georgia offers a robust external review process that's often successful for specialty medications when proper evidence is provided.

Internal Appeal (First Step)

  • Deadline: 180 days from denial notice
  • How to file: Call Cigna member services or submit written appeal
  • Timeline: Up to 30 days for pre-service; 60 days for post-service
  • Include: Medical necessity letter, seizure logs, REMS documentation

External Review (If Internal Appeal Fails)

  • Deadline: 60 days from final internal denial notice
  • Cost: Free to patients
  • Contact: Georgia Department of Insurance at 1-800-656-2298
  • Process: Independent medical reviewers evaluate your case
  • Timeline: 45 days for standard review; 72 hours for expedited urgent cases
  • Binding: If approved, Cigna must provide coverage

To file external review:

  1. Call Georgia DOI Consumer Services: 1-800-656-2298
  2. Request external review application form
  3. Submit form with denial letters and physician certification
  4. DOI assigns Independent Review Organization within 1 business day

Source: Georgia external review process

From Our Advocates

We've seen many Georgia families successfully overturn initial Fintepla denials by providing comprehensive seizure logs and clear documentation of why standard treatments failed. The key is showing the medical necessity through detailed records rather than just requesting coverage. This is a composite example based on common successful patterns, not any individual case.

Coverage Requirements at a Glance

Requirement What It Means Where to Find It Source
Prior Authorization Cigna approval needed before dispensing Submit via provider portal CNF-315 Policy
Formulary Tier Tier 4 specialty (higher copay) 2025 National Preferred List Cigna Formulary
Step Therapy Try 2+ other antiseizure medications first Failed trials documented CNF-315 Policy
Quantity Limits Dosing based on weight, REMS monitoring Per FDA labeling FDA Prescribing Information
Site of Care Specialty pharmacy only (Accredo/Express Scripts) Post-approval dispensing Cigna Provider Manual
REMS Program Mandatory safety monitoring Prescriber and patient enrollment Fintepla REMS
Echocardiogram Baseline and every 6 months Cardiac monitoring for safety REMS Requirements

Common Denial Reasons & How to Fix Them

Denial Reason How to Overturn Documents Needed
"Diagnosis not supported" Provide neurologist consultation notes Detailed diagnostic workup, EEG results, genetic testing
"REMS not enrolled" Complete REMS enrollment first Prescriber enrollment, patient enrollment, baseline echo
"Step therapy not met" Document failed prior medications Medication history with dates, reasons for failure/intolerance
"Not medically necessary" Submit comprehensive medical necessity letter Seizure logs, treatment history, clinical guidelines citations
"Experimental/investigational" Cite FDA approval for indication FDA labeling for Dravet syndrome/LGS, clinical trial data

Frequently Asked Questions

How long does Cigna prior authorization take in Georgia? Standard review takes 15-30 business days. Expedited review available in 72 hours for urgent medical situations where delays could harm the patient.

What if Fintepla is non-formulary on my Cigna plan? Request a formulary exception through your prescriber. Document why formulary alternatives have failed or are contraindicated. Cigna formulary exception process.

Can I request an expedited appeal in Georgia? Yes, both Cigna and Georgia's external review process offer expedited options when delays could seriously jeopardize your health or ability to regain maximum function.

Does step therapy apply if I failed medications outside Georgia? Yes, medication failures from other states count toward Cigna's step therapy requirements. Ensure your new Georgia neurologist has complete records from previous providers.

What's the difference between internal and external review? Internal review is Cigna reconsidering their own decision. External review involves independent medical experts through Georgia's Department of Insurance and is often more successful for complex cases.

How much does Fintepla cost with Cigna coverage? Costs vary by plan, but as a Tier 4 specialty medication, expect higher copays or coinsurance. UCB offers patient assistance programs that may help with out-of-pocket costs.

What if my neurologist isn't familiar with REMS enrollment? Direct them to www.FinteplaREMS.com or call REMS support at 1-877-964-3649. Prescriber training and enrollment are required before any coverage consideration.

For complex cases where initial appeals fail, Counterforce Health helps create targeted, evidence-backed appeals that address specific denial reasons and align with each payer's requirements.

Sources & Further Reading

Disclaimer: This guide provides educational information about insurance coverage processes and should not be considered medical advice. Always consult with your healthcare providers about treatment decisions. Insurance policies and state regulations may change; verify current requirements with official sources. For assistance with insurance appeals and coverage decisions, consider consulting with patient advocates or legal professionals experienced in healthcare coverage.

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.